A Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer

Condition:   Pancreatic Cancer Intervention:   Drug: Combination of metyrosine-derivative with low-dose sirolimus, phenytoin and methoxsalen Sponsor:   Tyme, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials